Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels

Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels

<i>Background:</i> Antifibrotic agents have been approved for the treatment of idiopathic pulmonary fibrosis (IPF). However, the efficacy of these drugs in the treatment of familial IPF (FIPF) has not been previously reported. <i>Case presentation:</i> We report the case of a...

Full description

Bibliographic Details
Main Authors: Yasuhiko Koga, Yoshimasa Hachisu, Hiroaki Tsurumaki, Masakiyo Yatomi, Kyoichi Kaira, Shoichiro Ohta, Junya Ono, Kenji Izuhara, Kunio Dobashi, Takeshi Hisada
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Medicina
Subjects:
familial
idiopathic interstitial pneumonia
pirfenidone
idiopathic pulmonary fibrosis
periostin
Online Access:https://www.mdpi.com/1010-660X/55/5/161

Internet

https://www.mdpi.com/1010-660X/55/5/161

Similar Items